← Back to patent-cliff list
SHR0410
Tier C — Watch / tradeSHR0410
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：KOR1
Indications (approved)：Postoperative pain, Pain, Pruritus, 急性疼痛
Regional status
US
-
EU
-
China
Phase III
2021-05-13
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of SHR0410?
Approved indications include: Postoperative pain, Pain, Pruritus, 急性疼痛.
When does the SHR0410 patent expire?
No public expiry year is available for SHR0410 yet; this page updates once verified.
How do I get a quote for SHR0410 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06